Grape is one of the main fruits produced worldwide being Vitis vinifera L. the most
cultivated specie. Approximately 71 % of the grape production is used in winemaking, while 27 %
in direct consumption as table grapes and 2 % as dried fruits. Epidemiological studies have
associated the consumption of grapes, grape juice and wine with a wide variety of healthpromoting
effects, particularly the reduced risk of cardiovascular diseases (CVDs), type-2
diabetes, certain types of cancers, and other chronic complications. The beneficial effects of grape
and grape-derived food products are believed to be related to a variety of bioactive components,
namely, phenolic acids, flavonols, flavanones, flavonoids, flavon-3-ols, anthocyanins,
procyanidins, sesquiterpenoids, monoterpenoids, and also C13 norisoprenoids. These bioactive
components are present mainly in grape skins and seeds and arise from different metabolic
pathways, namely acetyl-CoA and shikimic acids, via the intermediates mevalonate and aromatic
amino acids, respectively. In turn, C13 norisoprenoids derived from carotenoid oxidation. Most of
these compounds have strong antioxidant and anti-inflammatory properties and some of them
were already shown to be involved in different aspects of cell homeostasis. In vivo study using
different cancer cell lines reported that quercetin-3-glucoside, one of the major phenolic
compounds of grape skins, presented notable growth inhibitory effects in colon, breast,
hepatocellular and lung cancer cells. Malvidin-3-glucoside has pointed to other health benefits,
such as reduction of the incidence of CVDs, through the inhibition of the oxidation of human lowdensity
lipoproteins.
Figures - uploaded by
Rosa PerestreloAuthor contentAll figure content in this area was uploaded by Rosa Perestrelo
Content may be subject to copyright.